Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort. Kandel, M.; Allayous, C.; Dalle, S.; Mortier, L.; Dalac, S.; Dutriaux, C.; Leccia, M. T.; Guillot, B.; Saiag, P.; Lacour, J. P.; Legoupil, D.; Lesimple, T.; Aubin, F.; Beylot-Barry, M.; Brunet-Possenti, F.; Arnault, J. P.; Granel-Brocard, F.; Stoebner, P. E.; Dupuy, A.; Maubec, E.; Grob, J. J.; Dreno, B.; Rotolo, F.; Ballon, A.; Michiels, S.; Lebbe, C.; Borget, I.. Eur J Cancer. 2018; 33-40: p.33-40. doi:10.1016/j.ejca.2018.09.026
Article